79321550 - FIBROBODY

Information

• Trademark
• 79321550

• Source

• Serial Number

  79321550

• Registration Number

  6624524

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 18, 2021
  3 years ago

• Registration Date

  January 25, 2022
  3 years ago

• Transaction Date

  January 10, 2025
  29 days ago

• Status Date

  January 25, 2022
  3 years ago

• Published for Opposition Date

  November 09, 2021
  3 years ago

• Location Date

  January 25, 2022
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  ROACH, APRIL

• Law Office Assigned Location Code

  M60

• Owners

  • LinXis B.V.
  • LINXIS B.V

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical drugs for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents in the form of parenteral formulations and per-oral formulations, tablets and capsules that facilitate the delivery of pharmaceutical preparations; biochemical medicines for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; chemical preparations for pharmaceutical purposes, namely, for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease; drug delivery agents consisting of compounds that facilitate delivery of pharmaceutical preparations
• PM0001: FIBRO BODY
• GS0011: Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating fibrotic disease, liver- kidney- and lung fibrosis, inflammatory conditions with a proven fibrotic disease component and inflammatory bowel disease
• GS0441: Medical services, namely, in vitro analysis for medical and pharmaceutical use; medical services, namely, in vitro testing for medical and pharmaceutical use; consultancy and information services provided via the internet relating to pharmaceutical products
• GS0421: Pharmaceutical research services; conducting clinical trials for others relating to pharmaceuticals; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; scientific research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology

Case File Event Statements

• 9/30/2021 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 10/4/2021 - 3 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 10/6/2021 - 3 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/6/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/6/2021 - 3 years ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/12/2021 - 3 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 10/20/2021 - 3 years ago

  7 - NOTICE OF PUBLICATION Type: NPUB

• 11/9/2021 - 3 years ago

  8 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/18/2022 - 2 years ago

  11 - FINAL DISPOSITION PROCESSED Type: FIMP

• 1/25/2022 - 3 years ago

  9 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 2/24/2022 - 2 years ago

  10 - GRANT OF PROTECTION CREATED, TO BE SENT TO IB Type: GPAR

• 5/19/2022 - 2 years ago

  12 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 6/5/2022 - 2 years ago

  13 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 9/20/2024 - 4 months ago

  14 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH